VTCN1 and ovarian neoplasm: Given these multifaceted mechanisms of immune escape, there is growing interest in alternative immunotherapeutic strategies, particularly those targeting novel immune checkpoints such as B7-H3 and B7-H4, which are overexpressed in ovarian tumors and contribute to immunosuppression.